An active surveillance to monitor the real world safety in Indian patients prescribed nintedanib for the treatment of Idiopathic Pulmonary Fibrosis

First published 04/01/2017

Last updated 22/02/2024

EU PAS number:

EUPAS17055

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

clinical-trial-protocol-amendment-01_2

English (459.06 KB - PDF)View document

Updated protocol

1199-0280-Protocol-V5

First published: 22/02/2024

English (663.7 KB - PDF)View document

Study results

Study results

1199-0280-NIS Report

English (224.01 KB - PDF)View document

Study report

Other information